Therefore, our study aims to evaluate the expression of Toll-like receptors (TLR-2, TLR-3, TLR-4, and TLR-9) on NK and NKT-like cells in patients with gastric cancer (GC), compare these results with healthy volunteers (HV), and investigate variants depending on the cancer subtype. The gene discussed is TLR9; the disease is cancer.